This study reveals a novel mechanism by which curcumin inhibits CRC progression: by downregulating circHN1, it relieves suppression on miR-302a-3p, which in turn targets and downregulates PIK3R3, leading to reduced malignancy. The gene discussed is PIK3R3; the disease is colorectal carcinoma.